Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2024

Open Access 01.12.2024 | Case Report

Primary left ventricular leiomyosarcoma: a case report

verfasst von: Vipin Balachandran, Vanessa Young, Tina Baillie, Allen James

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Cardiac leiomyosarcomas are a rare subset of the already infrequent, primary malignant cardiac neoplasia spectrum. The most common site for a primary leiomyosarcoma of the ventricle is on the right with fewer than five globally reported cases in the left ventricle. Most present with non-specific symptoms but attention is usually sought after the appearance of compressive symptoms or arrhythmias. We present a case of a left ventricular leiomyosarcoma in a 50-year old female patient that had a delayed diagnosis and its subsequent surgical resection and oncological management with docetaxel and gemcitabine. This case highlights the need for a high index of suspicion for cardiac masses especially if there are competing chronic diseases with similar symptomatology. Given the rare presentation of left ventricular leiomyosarcomas, case reports may provide valuable information that is otherwise unavailable.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s13019-024-02680-4.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

A primary cardiac neoplasm is a rare diagnosis with a reported prevalence of between 0.001 and 0.03% in autopsy series. The most frequent malignant primary tumours are angiosarcomas with the rarest being leiomyosarcomas [1]. The location of malignant neoplasms also vary with angiosarcomas being commonly found in the right atrium and intimal sarcomas such as osteosarcomas and leiomyosarcomas arising from the left [2]. We present a case of an extremely rare primary cardiac leiomyosarcoma arising from the left ventricle which was surgically managed in the first instance.

Case report

A 50 year old female patient with a background of systemic lupus erythematosus presented to various hospitals with chest pain and shortness of breath over three years without any clear diagnosis. The history was also significant for sweats, low grade temperatures and weight loss of seven kilograms. A computerised tomograph (CT) of the chest was notable as having described a loculated intrapericardial effusion causing compression of the left ventricle (Fig. 1). Unfortunately, despite multiple imaging attempts, a diagnosis of a tumour was not made until recently when a trans-thoracic echocardiogram (TTE) showed the presence of a mass either arising from the pericardium or ventricle. A left video assisted thoracoscopic (VAT) pericardial window and biopsy of the mass was done which was reported as inflammatory tissue without evidence of malignancy.
A re-presentation with heart failure prompted a trans-oesophageal echocardiogram which demonstrated a mass compressing the left ventricle. A coronary angiogram was normal apart from feeding vessels into the tumour. Due to the multiple hospital admissions and new heart failure, a decision was made to excise the tumour.
A median sternotomy was performed and the patient placed on cardiopulmonary bypass cannulating the aorta and right atrium. A large mass arising from the apex of left ventricle was identified arising immediately lateral to the left anterior descending coronary artery and was carefully mobilised (Fig. 2a) Cardioplegic arrest allowed a full thickness ventriculotomy and subsequent removal of the tumour. The defect was repaired with a continuous 2 − 0 Prolene stitch followed by overlocking 4 − 0 Prolene with a Teflon buttress. The phrenic nerves were spared bilaterally. The patient was easily weaned off cardiopulmonary bypass but had to have the chest packed due to generalised coagulopathy. The chest was unpacked and closed primarily the following day after which she made an uneventful post-operative recovery.
A follow up TTE demonstrated a preserved left ventricular cavity size and systolic function (ejection fraction 70%) with apical akinesis presumably from where the tumour was removed.
Gross examination of the pathology revealed a 65 × 45 × 32 mm nodular mass attached to a portion of cardiac muscle (Fig. 3). The cut surface showed an infiltrative solid white lesion containing areas of necrosis and haemorrhage. Histologic examination revealed a pleomorphic spindle cell tumour with heterogenous, lobular architecture, widely invading the myocardium. The constituent tumour cells were spindled and epithelioid, arranged in diffuse sheets and interlacing fascicles within a background of variably myxoid stroma. A spectrum of nuclear atypia was seen, including moderately pleomorphic blunt nuclei with vesicular chromatin transitioning to areas with marked cytologic atypia. Frequent mitotic figures were identified, numbering up to 32 per 10 high power fields. Broad zones of necrosis were present and lymphovascular invasion was identified.
Immunohistochemistry revealed the tumour cells to be positive for smooth muscle actin and desmin (Fig. 3), with only focal positive staining for pan-cytokeratin and AE1/AE3. The tumour cells were negative for CK7, CK20, EMA, myogenin, MYO D1, STAT 6, calretinin, CD31, CD34, ERG, SOX 10, S100 and p40.
The morphologic features and immunohistochemical profile were in keeping with a high grade cardiac leiomyosarcoma.
Three cycles of docetaxel and gemcitabine chemotherapy was started by the treating oncology team after discharge from hospital. At the last surgical review in September 2020, the patient was well and fast approaching the one year mark from the initial surgery. PET scans performed until December 2021 did not pick up recurrence or metastasis but a CT scan performed in December 2021 picked up metastasis to the right lung along with a probably recurrence at the suture line. This was followed by evidence of metastatic disease to the neck in 2023. The patient passed away in late 2023 with a recurrence of the tumour in her lungs and concomitant heart failure.

Discussion

Primary cardiac tumours are exceedingly rare neoplasms comprising less than 1% of the 0.001–0.28% of all reported cardiac malignancies. The left atrium is the most common site reported in literature with the left ventricle being the rarest cardiac site [24]. Primary left ventricular leiomyosarcomas have not been well described in literature due to its rarity. Our case is also notable that it differs from previously published cases where the tumour was predominantly inside the left ventricular cavity whereas our case had a mass causing extrinsic LV compression [47]. A case report presented by Khalid et al. at the American Heart Association 2014 Scientific Sessions and Resuscitation Science Symposium bears similarities to our own with regards to the tumour location but unfortunately does not detail the peri-operative course [8].
Diagnosis has been reported to be straightforward with echocardiography, CT and MRI having very high sensitivity [4]. Unfortunately as is highlighted by our case, vague symptoms with the differential diagnosis confounded by the presence of chronic disease can lead the clinician into ordering imaging that does not focus on the heart. In a particularly unfortunate turn of events in this case, a biopsy of the mass via VAT returned inflammatory tissue. Regardless, we recommend the use of echocardiography and CT to aid in the diagnosis if vague cardiac symptoms are reported.
Wang et al. reported that surgery was the most common therapy provided followed by adjuvant chemotherapy. Incomplete resection was a feature of many of these cases due to the invasive nature of the tumour. This was also a feature of our case as the aim was for macroscopic resection of the tumour without aiming for strict neoplastic resection margins which would have left the patient with very little functioning ventricle.
Prognosis has been universally reported as poor with Wang et al. noting that the five year survival rate was 25.4%. Adjuvant chemotherapy was also noted to improve outcomes in many studies [3, 4].

Acknowledgements

The authors would like to acknowledge Dr. Antonino Bonaventura for his advice and explanations regarding the oncological management of this patient along with Adj Prof. Fiona Bonar for her expert opinions regarding the histopathology of the tumour.

Declarations

Ethical approval

The study was recorded as a negligible risk activity by the hospital ethics committee and an ethics approval was waived.
Informed consent was obtained from the patient for publication and presentation of the data from the case.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Andersen RE, Kristensen BW, Gill S. Cardiac leiomyosarcoma, a case report. Int J Clin Exp Pathol. 2013;6(6):1197.PubMedPubMedCentral Andersen RE, Kristensen BW, Gill S. Cardiac leiomyosarcoma, a case report. Int J Clin Exp Pathol. 2013;6(6):1197.PubMedPubMedCentral
2.
Zurück zum Zitat Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6(4):219–28.CrossRefPubMed Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management. Lancet Oncol. 2005;6(4):219–28.CrossRefPubMed
3.
Zurück zum Zitat Behi K, Ayadi M, Mezni E, Meddeb K, Mokrani A, Yahyaoui Y, et al. Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy. Clin Sarcoma Res. 2017;7(1):5.CrossRefPubMedPubMedCentral Behi K, Ayadi M, Mezni E, Meddeb K, Mokrani A, Yahyaoui Y, et al. Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy. Clin Sarcoma Res. 2017;7(1):5.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wang J-G, Cui L, Jiang T, Li Y-J, Wei Z-M. Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns. Asian Cardiovasc Thorac Ann. 2015;23(5):623–30.CrossRefPubMed Wang J-G, Cui L, Jiang T, Li Y-J, Wei Z-M. Primary cardiac leiomyosarcoma: an analysis of clinical characteristics and outcome patterns. Asian Cardiovasc Thorac Ann. 2015;23(5):623–30.CrossRefPubMed
5.
Zurück zum Zitat Fox J, Freitas E, McGifgin D, Firouz-Abadi A, West M. Primary leiomyosarcoma of the heart: a rare cause of obstruction of the left ventricular outflow tract. Aust N Z J Med. 1991;21(6):881–3.CrossRefPubMed Fox J, Freitas E, McGifgin D, Firouz-Abadi A, West M. Primary leiomyosarcoma of the heart: a rare cause of obstruction of the left ventricular outflow tract. Aust N Z J Med. 1991;21(6):881–3.CrossRefPubMed
6.
Zurück zum Zitat Jayle C, Christiaens L, Ardilouze P, Franco S, Corbi P. Left-ventricle leiomyosarcoma: imaging by multislices computed tomography with retrospective electrocardiogram-gated reconstruction. Thorax. 2007;62(3):280–280.CrossRefPubMedPubMedCentral Jayle C, Christiaens L, Ardilouze P, Franco S, Corbi P. Left-ventricle leiomyosarcoma: imaging by multislices computed tomography with retrospective electrocardiogram-gated reconstruction. Thorax. 2007;62(3):280–280.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Muehrcke DD, Justice K. Leiomyosarcoma of the left ventricle. Ann Thorac Surg. 2008;86(2):666.CrossRefPubMed Muehrcke DD, Justice K. Leiomyosarcoma of the left ventricle. Ann Thorac Surg. 2008;86(2):666.CrossRefPubMed
8.
Zurück zum Zitat Khalid HD, Grunloh DS, Bhatti AM, Rhee BJ, Orakzai S. A rare case of primary Cardiac Leiomyosarcoma Involving the Left ventricle. Circulation. 2014;130(suppl2):A14789. Khalid HD, Grunloh DS, Bhatti AM, Rhee BJ, Orakzai S. A rare case of primary Cardiac Leiomyosarcoma Involving the Left ventricle. Circulation. 2014;130(suppl2):A14789.
Metadaten
Titel
Primary left ventricular leiomyosarcoma: a case report
verfasst von
Vipin Balachandran
Vanessa Young
Tina Baillie
Allen James
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2024
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-024-02680-4

Weitere Artikel der Ausgabe 1/2024

Journal of Cardiothoracic Surgery 1/2024 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.